Science Explorer Back to mapMap
Discussion
Institution · PsiOxus Therapeutics (United Kingdom)

Most cited papers from PsiOxus Therapeutics (United Kingdom)

PsiOxus Therapeutics (United Kingdom)

What are the most cited papers from PsiOxus Therapeutics (United Kingdom)?

The most cited paper from PsiOxus Therapeutics (United Kingdom) is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "Challenges and directions in studying cell–cell communication by extracellular vesicles" (1,245) and "A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles" (584).

Showing 50 of 59 papers. Every paper with more than 18 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 Challenges and directions in studying cell–cell communication by extracellular vesicles Guillaume van Niel, David R. F. Carter, Aled Clayton et al. · Nature Reviews Molecular Cell Biology ReviewOpen access 8 Mar 2022 1,245
3 A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles Yvonne Couch, Edit I. Buzás, Dolores Di Vizio et al. · Journal of Extracellular Vesicles Open access Dec 2021 584
4 MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments Joshua A Welsh et al. · Journal of Extracellular Vesicles Open access 3 Feb 2020 527
5 Identification of storage conditions stabilizing extracellular vesicles preparations André Görgens et al. · Journal of Extracellular Vesicles Open access Jun 2022 425
6 Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence‐tagged vesicles as biological reference material André Görgens, Michel Bremer, Rita Ferrer-Tur et al. · Journal of Extracellular Vesicles Open access 21 Mar 2019 366
7 The power of imaging to understand extracellular vesicle biology in vivo Frederik J. Verweij et al. · Nature Methods Open access 26 Aug 2021 338
8 Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures Oscar P. B. Wiklander et al. · Frontiers in Immunology Open access 13 Jun 2018 269
9 A compendium of single extracellular vesicle flow cytometry Joshua A Welsh et al. · Journal of Extracellular Vesicles Open access Feb 2023 261
10 The viral protein corona directs viral pathogenesis and amyloid aggregation Kariem Ezzat et al. · Nature Communications Open access 27 May 2019 223
11 Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging Dhanu Gupta et al. · Journal of Extracellular Vesicles Open access 21 Aug 2020 217
12 Prevention of liver cancer cachexia-induced cardiac wasting and heart failure Jochen Springer et al. · European Heart Journal Open access 29 Aug 2013 212
13 Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial) Andrew J.S. Coats, Gwo Fuang Ho, Kumar Prabhash et al. · Journal of Cachexia Sarcopenia and Muscle Open access Jun 2016 177
14 An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells Joshua D. Freedman, Margaret R. Duffy, Janet Lei-Rossmann et al. · Cancer Research 18 Nov 2018 170
15 A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge Susanna Jane Dunachie et al. · Infection and Immunity Open access 20 Sep 2006 167
16 Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection Rocio García‐Carbonero, Ramón Salazar, Ignacio Durán et al. · Journal for ImmunoTherapy of Cancer Open access 2 Sep 2017 161
17 Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome Helena Sork, Giulia Corso, Kaarel Krjutškov et al. · Scientific Reports Open access 11 Jul 2018 147
18 Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification Cécile L. Maire et al. · Neuro-Oncology Open access 25 Jan 2021 146
19 Antibody-displaying extracellular vesicles for targeted cancer therapy Oscar P. B. Wiklander et al. · Nature Biomedical Engineering Open access 20 May 2024 138
20 Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours Franz Lennard Ricklefs et al. · Journal of Extracellular Vesicles Open access 21 Mar 2019 138
21 Heightened response of eosinophilic asthmatic patients to the CRTH 2 antagonist OC 000459 Roy Pettipher, Michael Hunter, Christopher M. Perkins et al. · Allergy 27 May 2014 133
22 A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE) Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey et al. · Journal for ImmunoTherapy of Cancer Open access 28 Jan 2019 108
23 Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles Dhanu Gupta et al. · Nature Biomedical Engineering Open access 6 Oct 2021 104
24 Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field Dragomira Majhen, Hugo Calderón, Naresh Chandra et al. · Human Gene Therapy 28 Feb 2014 103
25 Cell‐specific targeting of extracellular vesicles through engineering the glycocalyx Wenyi Zheng, Rui He, Xiuming Liang et al. · Journal of Extracellular Vesicles Open access Dec 2022 95
26 Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models Xiuming Liang, Zheyu Niu, Valentina Galli et al. · Journal of Extracellular Vesicles Open access Jun 2022 93
27 Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors Xiuming Liang et al. · Nature Communications Open access 29 Apr 2025 88
28 Label-Free Surface Protein Profiling of Extracellular Vesicles by an Electrokinetic Sensor Sara Cavallaro, Josef Horák, Petra Hååg et al. · ACS Sensors 25 Apr 2019 77
29 Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples Eleanor M. Scott, Egon J. Jacobus, Brian Lyons et al. · Journal for ImmunoTherapy of Cancer Open access 21 Nov 2019 76
30 The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats Mareike S. Pötsch, Anika Tschirner, Sandra Palus et al. · Journal of Cachexia Sarcopenia and Muscle Open access 21 Nov 2013 71
31 Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk Luzheng Xue, Joannah R. Fergusson, Maryam Salimi et al. · Journal of Allergy and Clinical Immunology Open access 19 Oct 2014 71
32 Expression of ICP0 Is Sufficient to Trigger Natural Killer Cell Recognition of Herpes Simplex Virus–Infected Cells by Natural Cytotoxicity Receptors Susan E. Chisholm, Keith Howard, Mar Valés Gómez et al. · The Journal of Infectious Diseases Open access 15 Mar 2007 64
33 Multiparametric Profiling of Single Nanoscale Extracellular Vesicles by Combined Atomic Force and Fluorescence Microscopy: Correlation and Heterogeneity in Their Molecular and Biophysical Features Sara Cavallaro, Federico Pevere, Fredrik Stridfeldt et al. · Small Open access 7 Mar 2021 62
34 High‐Resolution Imaging Flow Cytometry Reveals Impact of Incubation Temperature on Labeling of Extracellular Vesicles with Antibodies Tobias Tertel, Michel Bremer, Cécile L. Maire et al. · Cytometry Part A Open access 16 May 2020 62
35 The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: Andrew J.S. Coats, Venkatesan Srinivasan, J Surendran et al. · Journal of Cachexia Sarcopenia and Muscle Open access 15 Oct 2011 59
36 Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial Víctor Moreno, Maria-Pilar Barretina-Ginesta, Jesús García-Donás et al. · Journal for ImmunoTherapy of Cancer Open access Dec 2021 57
37 Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators Arthur Dyer, Ying Di, Hugo Calderón et al. · Molecular Therapy — Oncolytics Open access 15 Dec 2016 55
38 Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway Takahiro Seki, Fionnadh Carroll, Sam Illingworth et al. · Journal of Controlled Release Sep 2011 53
39 Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus Sam Illingworth, Ying Di, Maxine Bauzon et al. · Molecular Therapy — Oncolytics Open access 29 Mar 2017 49
40 The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria Tina S. Skinner‐Adams, Christopher L. Peatey, Karen Anderson et al. · Antimicrobial Agents and Chemotherapy Open access 27 Mar 2012 47
41 Surface display of functional moieties on extracellular vesicles using lipid anchors Wenyi Zheng, Melanie Schürz, Rim Jawad Wiklander et al. · Journal of Controlled Release Open access 24 Apr 2023 45
42 Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle Mariana Conceição, Laura Forcina, Oscar P. B. Wiklander et al. · Biomaterials Open access 5 Oct 2020 45
43 NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer Elaine Y L Leung, Darren P. Ennis, Philippa R Kennedy et al. · Molecular Therapy — Oncolytics Open access 14 Feb 2020 45
44 Development of chitosan–pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies Erdal Cevher, Stefan K. Salomon, Apostolos Makrakis et al. · Journal of Microencapsulation 31 Aug 2015 43
45 Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth Alison B. Tedcastle, Sam Illingworth, Alice Brown et al. · Molecular Therapy Open access 28 Dec 2015 41
46 Infrared Multiphoton Dissociation Enables Top‐Down Characterization of Membrane Protein Complexes and G Protein‐Coupled Receptors Corinne A. Lutomski, Tarick J. El‐Baba, Joshua D. Hinkle et al. · Angewandte Chemie International Edition Open access 17 Jun 2023 33
47 Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes Nalini Marino, Sam Illingworth, Prithvi Kodialbail et al. · PLoS ONE Open access 18 May 2017 32
48 MIFlowCyt‐EV: The Next Chapter in the Reporting and Reliability of Single Extracellular Vesicle Flow Cytometry Experiments Joshua A Welsh, Vera A. Tang, Edwin van der Pol et al. · Cytometry Part A Open access 17 Nov 2020 31
49 Tangential Flow Filtration with or Without Subsequent Bind-Elute Size Exclusion Chromatography for Purification of Extracellular Vesicles Joel Z. Nordin, Rakibe Beklem Bostancıoğlu, Giulia Corso et al. · Methods in molecular biology Book chapter 2019 29
50 Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia Yulia Elkina, Sandra Palus, Anika Tschirner et al. · International Journal of Cardiology 12 Oct 2013 29

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.